These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 24406159)
1. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
3. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance]. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484 [TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer. Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery. Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
9. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes. Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824 [TBL] [Abstract][Full Text] [Related]
10. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727 [TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma. Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365 [TBL] [Abstract][Full Text] [Related]
12. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy predicts lymph node metastasis in early gastric cancer: a retrospective analysis. Dong LF; Wang LB; Shen JG; Xu CY Dig Surg; 2012; 29(2):124-9. PubMed ID: 22538386 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
17. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma. Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of SPARC gene expression in patients with gastric cancer. Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911 [TBL] [Abstract][Full Text] [Related]
19. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D; Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691 [TBL] [Abstract][Full Text] [Related]
20. Multivariate prognostic study on large gastric cancer. Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]